SEC Form 4 · accession 0000914190-17-000219
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurence L Betterley
Officer — Chief Financial Officer
Period of report
Aug 7, 2017
Accepted (ET)
Aug 9, 2017 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 7, 2017 | A | 11,003 | $0.00 | A | 193,185 | D | |
| Common StockF2 | Aug 7, 2017 | A | 33,007 | $0.00 | A | 226,192 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $8.75 | holding | — | — | — | — | Mar 1, 2019 | Common Stock | 14,234 | 14,234 | D |
Explanation of responses
- F1Restrictions lapse as to 3,668 shares on 8/13/18 and 8/13/19 and as to 3,667 shares on 8/13/20.
- F2Subject to performance-based forfeiture based on the three year total shareholder return for fiscal years 2018, 2019 and 2020 versus the Company's peer group.
- F3Fully exercisable.